hyperalgesia
Interleukin-1 receptor antagonist (IL-1ra 0.1 microgram) reduced the development of SP-induced hyperalgesia up to 4 h after administration, but did not reverse an established hyperalgesia.
<span class="gene" id="8864563-9-0-33">Interleukin-1 receptor antagonist</span> (<span class="gene" id="8864563-9-35-41">IL-1ra</span> 0.1 microgram) reduced the development of SP-induced <span class="disease" id="8864563-9-95-107">hyperalgesia</span> up to 4 h after administration, but did not reverse an established <span class="disease" id="8864563-9-175-187">hyperalgesia</span>.